A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency
Condition: GHD Interventions: Drug: GenSci004; Drug: Genotropin Sponsor: GeneScience Pharmaceuticals Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials